Abstract
Objective
Young patients with familial syndromes have an increased metachronous cancer rate. Effective management is possible by identifying this high-risk group prior to index colectomy. The study surveys the Association of Coloproctology of Great Britain and Ireland (ACPGBI) membership preoperative evaluation and clinical management in young patients with colorectal cancer (CRC).
Method
An electronic survey was sent to the membership of the ACPGBI. The survey polled members on clinical scenarios relating to young-onset CRC patients. We were particularly concerned with preoperative management strategies, the extent of colectomy, and postoperative surveillance. Survey responses were collated and analysed.
Results
A total of 124 members responded to the survey and 74 completed the survey. Of these, 87.8 % would proceed to colectomy without preoperative tumor or genetic testing. Decisions regarding the extent of colectomy depended on family history. A total of 67 (90.6 %) would offer a limited colectomy with no family history, 49 (66.2 %) in a patient with familial CRC type X, 29 (39.2 %) in a young patient with Lynch syndrome. A similar trend was seen with young rectal cancer. Only 16 surgeons (21.6 %) could identify a syndrome of MYH-associated polyposis (MAP).
Conclusion
The majority of ACPGBI members will not offer preoperative risk testing based on a young age alone; however, the majority would alter their surgical strategy based on the results of this testing. MAP is poorly recognized by ACPGBI members and therefore an opportunity exists for education among members.
What is new in this paper?
This study is the first paper to survey the ACPGBI membership on management practices in young-onset CRC. Members are poor in adopting preoperative testing, alter surgical strategy based on a familial syndrome, with a minority recognizing MAP. An opportunity to improve education on young CRC patients exists.
Similar content being viewed by others
References
Southey MC, Jenkins MA, Mead L et al (2005) Use of molecular tumour characteristics to prioritise mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol 23:6524–6532
Farrington SM, Lin-Goerke J, Ling J et al (1998) Systematic analysis of hMSH2 and hMLH1 in young colon cancer patients and controls. Am J Hum Genet 63:749–759
Warrier SK, Trainer AH, Lynch AC et al (2011) Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy. Dis Colon Rectum 54:1480–1487
Church J (1998) Hereditary colon cancers can be tiny: a cautionary case report of the results of colonoscopic surveillance. Am J Gastroenterol 93:2289–2290
Vasen HF, Fm Nagengast, Khan PM (1995) Interval cancers in hereditary non-polyposis colorectal cancer (Lynch syndrome). Lancet 345:1183–1184
Lynch HT, Smyrk T, Jass JR (1995) Hereditary nonpolyposis colorectal cancer and colonic adenomas? Semin Surg Oncol 11:406–410
Parry S, Win AK, Parry B et al (2011) Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut 60(7):950–957
Lindor N, Rabe K, Petersen G et al (2005) Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. JAMA 293:1979–1985
Lichtenstein P, Holm NV, Versalo PK et al (2000) Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78–85
Delaney CP, Fazio VW, Remzi FH et al (2003) Prospective, age related analysis of surgical results, functional outcome, and quality of life after ileal pouch-anal anastomosis. Ann Surg 238:221–228
Kalady MF, McGannon E, Vogel JD et al (2010) Risk of colorectal adenoma and carcinoma after colectomy for colorectal cancer in patients meeting Amsterdam criteria. Ann Surg 252(3):507–513
http://www.acpgbi.org.uk/members/guidelines/documents-for-themanagementofcolorectal-cancer/
American Society of Colon and Rectal Surgeons. Hereditary colon cancer syndromes and genetic testing. http://www.fascrs.org/physicians/education/core_subjects/2012/hereditary_colon_cancer_syndromes/
Elton C, Makin K, Cohen CRG (2003) Outcome after ileorectal anastamosis. Br J Surg 90:59–65
Church JM, Fazio VW, Lavery IC, Oakley JR, Milsom J, McGannon E (1996) Quality of life after prophylactic colectomy and ileorectal anastomosis in patients with familial adenomatous polyposis. Dis Colon Rectum 39:1404–1408
Van Duijvendijik P, Slors JFM, Tatt CW, Oosterveld P, Vasen HFA (1999) Functional outcome after colectomy and ileorectal anastomosis compared with proctocolectomy and ileal pouch-anal anastomosis with familial adenomatous polyposis. Ann Surg 230:648–654
Ko CY, Rusin LC, Schoetz DJ Jr, Moreau L, Coller JA, Murray JJ et al (2000) Does better functional result equate with better quality of life? Implications for surgical treatment in familial adenomatous polyposis. Dis Colon Rectum 43:829–837
Lynch AC, Chruch JM, Lavery IC (2003) QOL following partial colectomy: relevance to hereditary non-polyposis colorectal cancer. Dis Colon Rectum 46:A55
Haanstra JF, de Vos tot Nederveen Cappel WH, Gopie JP et al (2012) Quality of life after surgery for colon cancer in patients with Lynch syndrome: partial versus subtotal colectomy. Dis Colon Rectum 55:653–659
You N, Chua H (2008) Segmental vs extended colectomy: measurable differences in morbidity, function, and quality of life. Dis Colon Rectum 51:1036–1043
Win AK, Parry S, Parry B et al (2013) Risk of metachonous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriers. Ann Surg Oncol 20(6):1829–1836
Kalady MF, Lipman J, McGannon E, Church JM (2012) Risk of colonic neoplasia after proctectomy for rectal cancer in hereditary nonpolyposis colorectal cancer. Ann Surg 255:1121–1125
Lovegrove RE, Tilney HS, Heriot AG et al (2006) A comparison of adverse events and functional outcomes after restorative proctocolectomy for familial adenomatous polyposis and ulcerative colitis. Dis Colon Rectum 49:1293–1306
Church J, Heald B, Burke C, Kalady M (2012) Understanding MYH-associated neoplasia. Dis Colon Rectum 55:359–362
Hendriks YM, Wagner A, Morreau H et al (2004) Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counselling and surveillance. Gastroenterology 127:17–25
Schmeler KM, Lynch HT, Chen LM et al (2006) Prophylactic surgery to reduce the risk of gynaecological cancers in the Lynch Syndrome. N Eng J Med 354:261–269
Shia J, Stadler Z, Weiser MR et al (2011) Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: how reliable are biopsy samples? Am J Surg Pathol 35(3):447–453
Maeda T, Cannom R, Beart RW Jr, Etzioni D (2010) Decision model of segmental compared with total abdominal colectomy for colon cancer in hereditary nonpolyposis colorectal cancer. J Clin Oncol 28(7):1175–1180
Burn J, Gerdes AM, Macrae F et al (2011) Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 378:2081–2087
Acknowledgments
The authors thank the ACPGBI members for answering the survey and thank the society secretariat, Anne O Mara for allowing us to distribute the survey via email to the respondents.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Warrier, S.K., Yeung, J.M., Lynch, A.C. et al. Managing Young Colorectal Cancer: A UK and Irish Perspective. World J Surg 38, 1827–1833 (2014). https://doi.org/10.1007/s00268-014-2470-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-014-2470-x